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1. Summary
Previous research has yielded inconsistent findings regarding the
ability of individuals with eating disorders (EDs) to recognize
facial emotion, making the clinical features of this population
hard to determine. This study tested the hypothesis that where
observed, emotion recognition deficits exhibited by patients
with EDs are due to alexithymia, a co-occurring condition
also associated with emotion recognition difficulties. Ability
to recognize facial emotion was investigated in a sample of
individuals with EDs and varying degrees of co-occurring
alexithymia, and an alexithymia-matched control group.
Alexithymia, but not ED symptomology, was predictive
of individuals’ emotion recognition ability, inferred from
tolerance to high-frequency visual noise. This relationship
was specific to emotion recognition, as neither alexithymia nor
ED symptomology was associated with ability to recognize
facial identity. These findings suggest that emotion recognition
difficulties exhibited by patients with ED are attributable to
alexithymia, and may not be a feature of EDs per se.
2. Introduction
Feeding and eating disorders (hereafter EDs) are axis I
disorders characterized by disturbed and inappropriate patterns
of eating [1]. Three subtypes are recognized, namely anorexia
nervosa (AN; associated with emaciation, distorted body
image and a fear of gaining weight), bulimia nervosa (BN;
2015 The Authors. Published by the Royal Society under the terms of the Creative Commons
Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted
use, provided the original author and source are credited.




associated with periods of bingeing, followed by inappropriate compensatory behaviour) and more
recently, binge eating disorder (BED; characterized by binge eating in the absence of the inappropriate
compensatory behaviours associated with BN). Although not a diagnostic criterion, it is also widely
believed that EDs are associated with atypical social and emotional functioning [2,3]. In particular,
several authors have reported deficits of facial emotion recognition in individuals with AN and BN
[4–7] and in non-clinical samples of women with high levels of ED symptomology [8,9]. This evidence is
contested, however, with several studies finding no evidence for impaired recognition of facial emotion
in ED samples [10–12]. Two recent meta-analyses of emotion recognition in ED [2,13] highlighted the
discrepancies between studies, noting that where observed, group differences in the recognition of
basic facial emotions are often small. In fact, the overall group difference fell short of significance in
a meta-regression [13].
Achieving a better understanding of putative emotion recognition deficits in ED populations
represents an urgent challenge to the field. Impaired recognition of others’ emotions can impede the
fluidity of social interactions and development and maintenance of relationships, by making it difficult
for individuals to respond appropriately to others’ expressions of emotion. Where observed in clinical
populations, affective difficulties may strain patients’ relationships, increasing the burden on themselves
and their support networks. Problems interpreting emotion may also contribute to and exacerbate clinical
symptoms, thereby impacting on treatment outcomes [14]. However, the current literature on emotion
recognition in EDs, characterized by inconsistency, does not support reliable conclusions about the nature
of EDs, and hampers the design and implementation of effective interventions. Beyond methodological
differences [2], it is possible that differing levels of co-occurring alexithymia present in ED samples have
contributed to this inconsistent literature.
Alexithymia is a non-clinical condition associated with problems identifying and describing one’s
own emotions [15]. Alexithymia frequently co-occurs with many developmental and psychological
disorders, including autism spectrum disorder (ASD), panic disorder, somataform disorders and
substance abuse [16]. Critically, however, alexithymia is an independent construct; many individuals
experience alexithymia without receiving a clinical diagnosis, and the presence of alexithymia
is not a necessary criterion for clinical diagnoses. Consistent with evidence that neurocognitive
mechanisms responsible for the subjective experience of emotion make a causal contribution to the
recognition of emotion in others, alexithymia is negatively associated with emotion recognition ability;
difficulties recognizing emotions—of negative valence in particular—are well established in non-
clinical alexithymic samples, and have recently been extended to clinical populations (see [16] for
a review).
The alexithymia hypothesis of affective impairment [17] suggests that co-occurring alexithymia
is responsible for equivocal reports of emotion recognition deficits across several clinical disorders.
Studies where the incidence of alexithymia in clinical samples exceeds that present in control groups
may be more likely to report emotion recognition deficits, than studies where levels of alexithymia
are similar across groups. Despite the well-established association between alexithymia and emotion
recognition abilities, few investigations of socio-emotional processing in clinical populations report
alexithymia levels, and fewer still employ control groups matched for alexithymia, or control for
co-occurring alexithymia statistically. Support for the alexithymia hypothesis is growing; in ASD
samples, individual differences in facial emotion recognition [18], ability to interpret vocal [19] and
musical [20] affect, and neural markers of empathy [21], are predicted by co-occurring alexithymia,
and not ASD per se. Similarly, putative deficits of emotion recognition in individuals with somatoform
disorder, relative to control participants, do not remain once alexithymia levels are controlled
for [22].
Alexithymia co-occurs with all ED subtypes [23,24], and with non-clinical ED symptomology [8,25].
Despite high co-occurrence between EDs and alexithymia, however, these constructs are distinct [26].
Significantly, poor emotion recognition and high levels of alexithymia have previously been reported in
the same ED sample [27], raising the possibility that alexithymia, not ED symptomology, is responsible
for emotion recognition difficulties.
We tested the hypothesis that, where observed, difficulties recognizing facial emotion experienced
by ED patients are not a symptom of EDs, but are instead owing to alexithymia. Individuals with EDs
and an alexithymia-matched control group completed a novel emotion recognition procedure, whereby
tolerance to visual noise indexed ability to recognize facial emotion. A comparable identity recognition
procedure was employed as a control task. We hypothesized that alexithymia, but not ED symptomology,
would predict facial emotion recognition abilities, and that these would not differ between clinical and
alexithymia-matched control groups.






Twenty-one females with an ED (19 AN, two BN; mean age = 23.38 years, s.d. = 6.31) and 21 females
with no past or present psychological disorder (mean age = 25.67 years, s.d. = 6.57) participated in the
study. Pilot data obtained using the current task in a group of 12 typical individuals were used in a
power analysis, conducted using GPOWER, to indicate that the correlation between alexithymia and
global emotion threshold (with effect size of 0.483) should reach significance (where power = 0.95, α =
0.05) with a sample size of 38. As pilot data did not include an ED group, however, and the current task
differs from emotion recognition tasks previously used, a power calculation could not be performed in
order to determine the necessary sample size for the group difference to reach significance. As previous
ED emotion recognition studies have employed a minimum of 20 participants in each group [2], the
sample size indicated by the power analysis was increased, to include 21 participants in both the ED and
control groups.
All participants gave informed consent prior to participation. All individuals with an ED were
diagnosed by independent clinicians, according to DSM-IV [28] or DSM-V [1] criteria. Fourteen of the
21 ED participants, diagnosed more than 1 year prior to study participation, also completed the EDs
section of the research version of the structured clinical interview for DSM-IV (SCID) [29]. One member
of the ED group had not previously been diagnosed by a clinician, but scored above the recommended
cut-off for clinical significance on the eating disorder examination questionnaire (EDE-Q) [30], had a BMI
below the healthy weight cut-off (16.5) and met criteria for ‘anorexia, binge-purging type’ according to
the SCID. This participant was not an outlier in any analysis, and her exclusion did not alter the pattern of
results. The ED group had significantly higher ED symptomology (M= 4.19, s.d. = 1.66), as assessed by
the EDE-Q, than the control group (M= 1.30, s.d. = 1.36) [t40 = 6.169, p< 0.001, d= 1.951, CI(1.94, 3.83)].
The ED and control groups were matched for age [t40 = 1.15, p= 0.257, d= 0.364, CI(−6.30, 1.73)],
IQ measured by the Wechsler abbreviated scale of intelligence [31] [t40 = 0.57, p= 0.578, d=
0.180, CI(−4.58, 8.11)], and alexithymia measured by the Toronto alexithymia scale (TAS-20) [32]
[t40 = 1.24, p= 0.222, d= 0.392, CI(−14.03, 3.36)]. Seven participants (33%) in the control group (M=
49.95, s.d. = 15.45) and nine participants (42%) in the ED group (M= 55.29, s.d. = 12.25) met the criterion
for severe alexithymia (TAS-20 score > 60). TAS-20 scores ranged from 26 to 79 in the control group,
and 26 to 73 in the ED group. Although alexithymia and depression are independent constructs [33],
the importance of controlling for depression in studies of EDs and alexithymia is well established
[34,35]. Depression levels were therefore measured in all participants using the depression, anxiety
and stress scale [36]. Depression was significantly associated with both ED symptomology (r40 = 0.655,
p< 0.001) and alexithymia (r40 = 0.384, p= 0.012), and differed significantly between the ED (M= 22.26,
s.d. = 11.08) and control groups (M= 5.38, s.d. = 6.98) [t40 = 5.91, p< 0.001, d= 1.869, CI(11.11, 22.66)].
All questionnaire measures were completed prior to the experiment.
3.2. Stimuli and materials
Emotional face stimuli were taken from the STOIC database [37] and supplemented by stimuli purposely
created for the study, yielding a total of 49 stimuli. The stimulus set used in the test phase comprised
seven male identities, expressing happiness, sadness, surprise, fear, disgust, anger and pain (see figure 1
for examples). An additional seven images showing the seven identities with an emotionally neutral
expression were used during training. Each stimulus was a greyscale image depicting a face, cropped
to remove external features. Stimuli were presented on a 15′′ LCD screen and subtended approximately
8◦ × 7◦ when viewed at a distance of 60 cm.
3.3. Training procedure
Two trial-to-criterion training phases, whereby participants were required to meet predetermined criteria
before progressing, preceded the experimental task, allowing participants to learn the names of the
seven identities. In the first training phase, participants viewed seven emotionally neutral identities
and were prompted to select a particular identity (e.g. ‘pick Oscar’) using key presses. The location
of each identity was randomized throughout. The second training phase ensured that participants
could correctly identify each face when presented in isolation; i.e. without the other identities present
for comparison. Participants viewed one facial identity and had to select the correct name from the


















Figure 1. Examples of stimuli, showing all seven emotions (happiness, sadness, disgust, anger, surprise, fear and pain) each expressed
on one of the seven identities (Dylan, Colin, Barry, Joey, Ray, Oscar and Hugo). During the experimental procedure, each emotion was
equally likely to be expressed by each of the seven identities, ensuring that identity and emotion were not confounded. Examples show
stimuli obscured by increasing levels of visual noise (10%, 30%, 50%, 70% and 90%).
seven options. A screen showing the seven identities with their corresponding names preceded both
training tasks. Stimuli remained visible until participants responded, and were followed by accuracy
feedback alongside the correct answer. On both training tasks, participants were required to correctly
and consecutively identify the seven individuals twice in order to proceed. This ensured that participants
had sufficiently memorized the identities. Participants did not receive training in emotion recognition,
nor was their ability to recognize emotions measured prior to the test procedure, as this may have
altered participants’ recognition performance in the experimental paradigm, and emotional expressions
are encountered in daily life, unlike the novel identities.
3.4. Test procedure
Experimental trials began with a fixation point (1000 ms) followed by a single facial image, depicting
one of the seven possible identities exhibiting an emotional expression (800 ms). This was replaced
by a prompt to attribute either emotion (e.g. ‘anger: yes or no?’) or identity (e.g. ‘Oscar: yes or no?’).
Importantly, identical stimuli were used to test emotion and identity recognition, and emotion and
identity trials were interleaved. Participants were therefore unaware whether they would have to judge
identity or emotion when viewing each stimulus. This feature of the design ensured that both attributes
had to be processed simultaneously, as is the case in real-life interactions. The attribution prompt
remained visible until participants responded with a key press.
Participants’ emotion and identity recognition ability was estimated by determining their tolerance to
high-frequency visual noise (figure 1). An adaptive staircase procedure was used whereby the amount of
noise superimposed on each stimulus image was varied incrementally, to determine the maximum level
of noise participants could tolerate and still recognize each emotion and identity reliably (hereafter their
recognition threshold). Higher thresholds are indicative of superior recognition ability. Initial threshold
estimates for each of the seven identities and emotions were set at 50%, and remained at this level
for the first 84 trials (six presentations per emotion and identity). Thereafter, if participants correctly




Table 1. Means and standard deviations for recognition thresholds demonstrated by control and eating disorder (ED) groups, with
t-tests for group differences, and correlations with alexithymia and ED symptomology. (Alexithymia is measured by the Toronto
alexithymia questionnaire (TAS-20), whereas ED symptomology is measured by the eating disorder examination questionnaire (EDE-Q).
None of themeasures of emotion or identity recognitionwas associatedwith ED symptomology. Alexithymiawas significantly negatively
correlated with the threshold for global emotion recognition, and for happiness, disgust and pain recognition. There was also a strong
trend for alexithymia to be negatively correlated with anger recognition threshold. ∗p< 0.05; ∗∗p< 0.025.)
attribute control mean (s.d.) % ED mean (s.d.) % group contrast correlation with EDE-Q correlation with TAS-20
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
emotion 62.0 (11.3) 57.3 (18.8) t40 = 0.978 r = 0.024 r = −0.340∗
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
identity 47.3 (20.3) 43.8 (20.8) t40 = 0.546 r = 0.021 r = −0.226
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
happiness 70.9 (18.9) 76.1 (17.8) t40 = 0.907 r = 0.226 r = −0.305∗
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
sadness 68.6 (14.3) 68.8 (26.3) t40 = 0.029 r = 0.151 r = −0.135
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
disgust 51.0 (19.6) 51.4 (24.5) t40 = 0.056 r = −0.069 r = −0.381∗∗
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
anger 53.8 (23.3) 45.2 (30.2) t40 = 1.022 r = 0.004 r = −0.301
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
surprise 84.2 (12.2) 73.6 (24.7) t40 = 1.766 r = −0.055 r = −0.026
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
fear 38.5 (22.3) 34.0 (26.8) t40 = 0.595 r = 0.081 r = −0.133
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
pain 66.9 (21.9) 52.1 (27.0) t40 = 1.947 r = −0.166 r = −0.323∗
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
recognized a particular emotion or identity twice consecutively, or made a single incorrect response,
that noise parameter was increased (making that attribution harder on subsequent trials) or decreased
(making that attribution easier on subsequent trials), respectively. The noise manipulation was achieved
by replacing a given proportion (initially 50%) of the greyscale intensity values comprising the image
with zeros, setting them to black. Intensity values were selected for distortion at random, sampling the
entire facial image uniformly.
The size of each stepwise increment decreased as participants progressed through the experiment.
From the 85th trial until the 140th trial, stepwise adjustments of ±16% were made. In the second, third,
fourth and fifth blocks (each comprising 140 trials), the stepwise adjustments were decreased to ±8%,
±4%, ±2% and ±1%, respectively. Large increments early in the procedure ensured that the staircase
quickly arrived at the approximate threshold for each identity and emotion. Smaller increments towards
the end of the procedure ensured that threshold estimates became more stable as participants approached
their maximum level of tolerance, and allowed estimates to be ‘fine-tuned’. The 14 threshold estimates
(seven emotions, seven identities) reached after 700 trials (50 trials per emotion and identity) were taken
as the final recognition thresholds for that participant. Prior to the experimental paradigm, participants
completed five practice trials to familiarize themselves with the format of experimental trials.
A subset of individuals who took part in the pilot study (eight typical participants) completed the task
a second time, in order for test–retest reliability of the current paradigm to be determined. Test–retest
reliability analysis revealed a trend for global emotion thresholds to correlate across the two time points
(r= 0.513, p= 0.073), and a significant correlation between global identity thresholds across the two time
points (r= 0.641, p= 0.018). Importantly, this suggests that a specific deficit in emotion recognition could
not simply be explained by reduced reliability of the identity task.
4. Results
In addition to the 14 recognition thresholds (seven emotions, seven identities) estimated for each
participant, global emotion and identity thresholds were calculated by averaging across the seven
individual emotion and identity estimates. These global measures of recognition ability for identity and
emotion are directly comparable—each is a composite of the thresholds estimated for seven categories,
comprising seven exemplars. Associations between the resulting distributions, alexithymia and ED
symptomology were then determined (table 1).
Alexithymia severity was negatively correlated with global emotion thresholds (r40 = −0.340,
p= 0.027), but not with global identity thresholds (r40 = −0.226, p= 0.150). Significant simple
correlations were observed between alexithymia severity and happiness threshold (r40 = −0.305,
p= 0.049), disgust threshold (r40 = −0.381, p= 0.013) and pain threshold (r40 = −0.323, p= 0.037). The
























r = –0.381 r = –0.305
r = –0.301 r = –0.323
20 30 5040 60
TAS-20 score






















































Figure 2. Scatter plots with best-fitting regression lines showing recognition thresholds for disgust, happiness, anger and pain
recognition. Recognition thresholds are shown for individuals in the eating disorder and control groups, as a function of their score on
the Toronto alexithymia scale (TAS-20). A greater score on the TAS-20 indicates more severe levels of alexithymia.
correlation between alexithymia and anger threshold also approached significance (r40 = −0.301, p=
0.053). Scatter plots depicting these simple correlations can be seen in figure 2. Recognition of the
remaining emotions—sadness, surprise and fear—also showed negative correlations with alexithymia
severity, but fell short of statistical significance.
In order to determine the impact of ED diagnosis on emotion and identity recognition, a 2 (ED
group) × 2 (task: global emotion threshold versus global identity threshold), analysis of variance was
performed on the emotion and identity recognition thresholds. Neither the main effect of ED group
(F1,40 = 0.68, p= 0.416, η = 0.017), nor the ED group × task interaction (F1,40 = 0.05, p= 0.819, η = 0.001)
was significant. Follow-up t-tests were conducted to separately assess the impact of ED group on
each of the tasks individually. As predicted by the alexithymia hypothesis of affective impairment,
individuals with EDs and control participants matched for co-occurring alexithymia demonstrated
equivalent recognition thresholds for facial emotion (t40 = 0.978, p= 0.334, d= 0.309, CI(−0.05, 0.14)) and
identity (t40 = 0.546, p= 0.588, d= 0.137, CI(−0.09, 0.16)). There was no difference between the groups in
ability to recognize any of the seven individual emotions and no correlation between EDE-Q score and
either emotion or identity recognition thresholds (table 1).
Together, these results suggest that ED symptomology is unrelated to emotion and identity
recognition ability, whereas alexithymia explains substantial variation in participants’ ability to recognize
facial emotion. Nevertheless, it is important to determine whether the significant relationships observed
between alexithymia and emotion recognition survive once individuals’ depression scores are accounted
for [34,35]. In addition, individual differences attributable to age and IQ—variables known to affect
performance on face perception tasks—may prevent detection of simple correlations between ED
symptomology and emotion recognition ability.
To address these issues, hierarchical regression analyses were conducted on the global emotion and
global identity thresholds. Depression scores, age and IQ, were entered in the first step of the regression
model, followed by alexithymia in the second step, and ED symptomology in the third. Alexithymia was
found to be a significant predictor of the emotion recognition thresholds over and above the demographic
variables (t40 = 2.422, p= 0.020, d= 0.766), and its addition to the model increased the variance accounted




Table 2. (a) Regression models for the prediction of emotion recognition threshold, including demographic variables (age, IQ and
depression) in the first step, alexithymia, measured by the TAS-20 in the second step, and ED symptomology, measured by the EDE-Q in
the third. (b) Regression models including demographic variables in the first step, ED symptomology in the second step, and alexithymia
in the third. (Both hierarchical regressions indicate that alexithymia does, and ED symptomology does not, predict emotion recognition
threshold over and above demographic variables, regardless of the order they were entered into the regression model.)
step predictor β p R2 (%) R2 (p)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1 age −0.012 0.001 25.9 25.9% (0.009)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ 0.002 0.388
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression −0.002 0.259
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 age −0.011 0.001 36.0 10.1% (0.020)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ 0.002 0.257
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression 0.000 0.853
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
alexithymia −0.004 0.020
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3 age −0.011 0.001 38.4 2.3% (0.249)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ 0.002 0.249
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression −0.002 0.399
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
alexithymia −0.004 0.015
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ED symptomology 0.015 0.249
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(b)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1 age −0.012 0.001 25.9 25.9% (0.009)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ 0.002 0.388
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression −0.002 0.259
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 age −0.011 0.002 27.1 1.2% (0.439)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ 0.002 0.389
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression −0.003 0.178
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ED symptomology 0.011 0.439
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3 age 0.011 0.001 38.4 11.3% (0.015)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ 0.002 0.249
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression −0.002 0.399
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ED symptomology 0.015 0.249
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
alexithymia −0.004 0.015
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
for by 10.1%. ED symptomology, when added in the third step of the model, did not predict emotion
recognition threshold significantly and yielded a non-significant increase in the variance accounted for
(2.3%). When global identity threshold was also controlled for in the first step of the model, the predictive
ability of alexithymia fell to a two-tailed trend (p= 0.065).
Although the control and ED groups were approximately matched for alexithymia, a significant
correlation was observed between alexithymia and ED symptomology (r40 = 0.343, p= 0.026). To ensure
that multicollinearity between these variables did not obscure a relationship between ED symptomology
and emotion recognition ability, a further regression analysis was conducted: depression scores, age and
IQ were again entered in the first step, but now followed by ED symptomology in the second step, and
alexithymia third. ED symptomology again failed to predict recognition thresholds for emotion, whereas
alexithymia remained a significant predictor (t40 = 2.56, p= 0.015, d= 0.812), increasing the variance
accounted for by 11.3%. See table 2 for a summary of the regression models.




In a convergent analysis, partial correlation coefficients were computed between emotion threshold
and alexithymia, and emotion threshold and EDs, adjusted for age, IQ and depression. Partial coefficients
were compared using Steiger’s Z-test. Results showed a significantly stronger relationship between
alexithymia and emotion threshold than that between emotion threshold and ED, whether ED was
measured using EDEQ scores (z= 1.75, p< 0.05), or as a categorical variable (z= 2.25, p= 0.01).
Finally, hierarchical regression analyses were also conducted for the recognition thresholds calculated
for the seven individual emotions. Recognition ability for happiness, anger and disgust was significantly
predicted by alexithymia and not ED symptomology, having taken account of age, IQ and depression,
irrespective of the order alexithymia and ED symptomology were entered into the model (table 3).
Although a significant simple correlation was observed between alexithymia and recognition of pain,
alexithymia failed to predict pain thresholds once the variance attributable to age, IQ and depression
was accounted for (p= 0.064). Overall, these results indicate that alexithymia, and not ED symptomology,
explains emotion recognition.
5. Discussion
According to the alexithymia hypothesis of affective impairment [17], where observed, emotion
recognition deficits in individuals with EDs are, in fact, owing to co-occurring alexithymia and should not
be regarded as a core feature of these conditions. To test this assertion, this study compared facial emotion
recognition ability in individuals with an ED and an alexithymia-matched control group. Consistent
with the alexithymia hypothesis of impaired emotion recognition, the ED and alexithymia-matched
control groups demonstrated comparable recognition of facial emotion and identity. Crucially, however,
alexithymia, not ED symptomology, was found to predict emotion recognition ability; severe alexithymia
was associated with impaired emotion recognition, whereas ED diagnosis was unrelated to emotion
recognition thresholds. Importantly, this relationship remained once age, IQ and depression, were taken
into account.
These results shed light on the inconsistent literature on emotion recognition in ED populations.
Several authors have reported evidence for impaired recognition of facial emotion in EDs [4–6],
prompting speculation that atypical emotion processing may be an important feature of these conditions
[2]. The current findings suggest that emotion recognition impairment is, in fact, unrelated to EDs per
se, and that heterogeneity of ED samples, with respect to alexithymia, is probably responsible for many
of the contradictory findings reported previously. Where impaired emotion recognition in ED samples
has been reported, clinical groups may have contained a greater proportion of individuals with severe
alexithymia than control groups [27].
The current findings further support the suggestion that co-occurring alexithymia may explain
inconsistent reports of impaired emotion recognition across a range of disorders [17]. Many conditions
are associated with elevated rates of alexithymia, and equivocal reports of emotion recognition deficits
[16]. Recognition of facial emotion in autism was predicted by levels of co-occurring alexithymia and not
by the presence or severity of autism [18]; a pattern replicated in this study with an ED sample. These
convergent findings suggest that co-occurring alexithymia can produce similar emotion recognition
difficulties in different clinical conditions. It is therefore crucial that future studies of emotion recognition
in clinical populations match control groups for alexithymia, or control for its influence statistically,
allowing researchers to test whether condition symptomology makes an independent contribution to
emotion recognition.
The individual emotion thresholds most strongly related to alexithymia in this study were happiness,
disgust and anger. While the relationship with disgust and anger recognition accords well with
Cook et al.’s [18] recent findings in ASD, the association with happiness recognition is observed less
often, and contradicts the view that alexithymia is disproportionately related to impaired recognition
of emotions with negative valence (see [16] for a review). Where recognition deficits are restricted
to negative emotions, it is unclear whether this pattern reflects the ease with which happiness may
be discriminated. Happiness is often the only emotion studied with a positive valance and happy
expressions have highly distinctive local features [38]. In this study, ceiling effects were avoided
by increasing difficulty for each emotion independently, by altering levels of visual noise based on
performance. In addition, although the current procedure ensured that pain and happiness were
assessed independently, the presence of pain is likely to have made happiness harder to discriminate
than in previous studies, owing to expressions of pain sharing more physical features with happiness
expressions than do other negative facial emotions.




Table 3. (a) Regression models for the prediction of happiness, anger, disgust and pain recognition thresholds, including demographic
variables (age, IQ and depression) in the first step, alexithymia, as measured by the TAS-20 in the second step, and ED symptomology,
as measured by the EDE-Q in the third. (For happiness, anger and disgust, alexithymia significantly predicts recognition threshold, above
demographic variables, whilst ED symptomology is not predictive. For pain, once demographic variables are accounted for, the predictive
ability of alexithymia falls short of significance.) (b) Regressionmodels for thepredictionof happiness, anger, disgust andpain recognition
threshold, includingdemographic variables in thefirst step, ED symptomology in the second step, and alexithymia in the third. (Aswas the
case when alexithymia was entered into the model before ED symptomology, for happiness, anger and disgust, it was alexithymia, and
not ED symptomology, which significantly predicted recognition threshold, over and above demographic variables. For pain, alexithymia
was no longer a significant predictor of recognition threshold once demographic variables were accounted for.)
step predictor B p R2 R2 (p) β p R2 R2 (p)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(a) happiness recognition threshold anger recognition threshold
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1 age −0.003 0.459 4.5% 4.5% (0.620) −0.017 0.010 16.8% 16.8% (0.070)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ −0.002 0.400 0.002 0.561
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression 0.001 0.528 −0.001 0.840
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 age −0.003 0.479 17.6% 13.1% (0.020) −0.016 0.008 27.4% 10.6% (0.025)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ −0.002 0.504 0.003 0.409
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression 0.004 0.127 0.002 0.487
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
alexithymia −0.005 0.020 −0.007 0.025
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3 age −0.003 0.518 23.8% 6.2% (0.097) −0.016 0.009 27.5% 0.1% (0.866)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ −0.002 0.509 0.003 0.414
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression 0.001 0.797 0.002 0.654
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
alexithymia −0.006 0.011 −0.007 0.027
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ED symptomology 0.029 0.097 0.004 0.866
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
disgust recognition threshold pain recognition threshold
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1 age −0.013 0.014 15.4% 15.4% (0.092) −0.010 0.101 18.2% 18.2% (0.052)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ 0.001 0.829 0.007 0.081
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression −0.002 0.456 −0.005 0.086
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 age −0.013 0.011 29.3% 13.9% (0.010) −0.009 0.102 25.5% 7.3% (0.064)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ 0.001 0.630 0.007 0.051
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression 0.001 0.772 −0.003 0.352
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
alexithymia −0.006 0.010 −0.005 0.064
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3 age −0.013 0.012 29.3% 0.0% (0.956) −0.009 0.108 25.6% 0.0% (0.951)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ 0.001 0.634 0.007 0.054
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression 0.001 0.845 −0.003 0.440
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
alexithymia −0.006 0.012 −0.005 0.069
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ED symptomology 0.001 0.956 0.001 0.951
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(b) happiness recognition threshold anger recognition threshold
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1 age −0.003 0.459 4.5% 4.5% (0.630) −0.017 0.010 16.8% 16.8% (0.070)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ −0.002 0.400 0.002 0.561
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression 0.001 0.528 −0.001 0.840
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 age −0.003 0.489 8.4% 3.9% (0.216) −0.017 0.011 16.8% 0.0% (0.899)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ −0.002 0.397 0.002 0.566
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression −0.001 0.740 0.000 0.946
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
alexithymia 0.023 0.216 −0.003 0.899
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(Continued.)






step predictor B p R2 R2 (p) β p R2 R2 (p)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3 age −0.003 0.518 23.8% 15.3% (0.011) −0.016 0.009 27.5% 10.7% (0.027)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ −0.002 0.509 0.003 0.414
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression 0.001 0.797 0.002 0.654
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
alexithymia 0.029 0.097 0.004 0.866
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ED symptomology −0.006 0.011 −0.007 0.027
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
disgust recognition threshold pain recognition threshold
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1 age −0.013 0.014 15.4% 15.4% (0.092) −0.010 0.101 18.2% 18.2% (0.052)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ 0.001 0.829 0.007 0.081
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression −0.002 0.456 −0.005 0.086
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 age 0.005 0.015 15.6% 0.2% (0.783) −0.010 0.104 18.3% 0.1% (0.856)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ 0.003 0.831 0.007 0.086
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression 0.004 0.703 −0.005 0.238
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ED symptomology 0.021 0.783 −0.004 0.856
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3 age 0.005 0.012 290.3% 13.8% (0.012) −0.009 0.108 25.6% 7.2% (0.069)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IQ 0.003 0.634 0.007 0.054
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
depression 0.003 0.845 −0.003 0.440
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ED symptomology 0.020 0.956 0.001 0.951
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
alexithymia 0.002 0.012 −0.005 0.069
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
The influence of co-occurring alexithymia may extend beyond expression recognition, potentially
explaining a wide range of emotion processing difficulties observed in EDs. Alexithymia is associated
with impaired performance when judging protagonists’ emotions from vignettes, in ED participants [39]
and individuals with non-clinical disordered eating [8]. While the independent contributions of ED and
alexithymia were not addressed, these findings suggest that the impact of co-occurring alexithymia in
ED samples may extend to broader socio-emotional abilities. We also note that co-occurring alexithymia
is known to be responsible for the difficulties interpreting vocal [19] and musical affect [20], and the
reduced empathy [21], seen in some individuals with ASD.
The current ED sample did not contain sufficient numbers of BN or BED patients to determine how the
association with alexithymia varies as a function of ED subtype. Alexithymia co-occurs with all subtypes
[23,24], however, and neither BN patient was an outlier. Determining whether alexithymia produces
equivalent deficits of facial emotion recognition in each subtype remains a priority for future research,
especially as only one study has directly compared emotion recognition ability across ED subtypes [23].
Similarly, while the sample size was modest, it was sufficient to observe reliable associations between
alexithymia and emotion recognition ability. A power calculation suggested that over 4500 patients
would be required for the observed effect of EDs on emotion recognition to reach significance, suggesting
the effect of alexithymia on emotion recognition is an order of magnitude greater than that of EDs.
As expected, no association was seen between alexithymia or ED symptomology and identity
recognition ability. Although a weak negative relationship was observed between alexithymia and
identity recognition, this may reflect top-down effects, whereby individuals with high alexithymia,
aware of their emotion recognition problems, attend to cues to facial emotion at the expense of
identity recognition. Indeed, anecdotal accounts during debriefing suggest this may be the case. Short
presentation durations coupled with the demand to process identity and emotion simultaneously,
may have proved challenging for individuals with high levels of alexithymia. That no relationship
was seen between alexithymia and identity recognition thresholds confirms that alexithymia is
associated with problems of emotion interpretation and not simply impaired interpretation of degraded
visual images.
Overall, these findings suggest that levels of co-occurring alexithymia, and not ED symptomology,
predict ability to recognize facial emotion, in individuals with and without EDs. These results





have significant implications for the conceptualization of EDs—suggesting that disordered emotion
processing may not be a core feature of these conditions—as well as for socio-emotional research
practice—highlighting the need to measure and control for the influence of co-occurring alexithymia
when testing clinical populations. Together with previous findings, these results suggest that alexithymia
may explain individual differences in affective processing across a range of clinical conditions.
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